Related Experiment Video
Updated: Apr 5, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Initiation & completion rates of hepatitis A vaccination among US pediatric populations born between 2005 and 2009
Thomas Weiss1, Dongmu Zhang1, Nagesh N Borse2
1Center for Observational and Real-World Effectiveness, Merck & Co., Inc., Kenilworth, NJ, USA.
Insights
Many children still miss hepatitis A vaccination series initiation and completion. Identifying missed opportunities and ensuring timely vaccination is crucial for preventing this disease.
Area of Science:
- Pediatric infectious diseases
- Vaccinology
- Public health
Background:
- Hepatitis A remains a public health concern, necessitating high vaccination coverage.
- Understanding vaccination patterns is key to improving public health outcomes.
Purpose of the Study:
- To determine hepatitis A vaccine series initiation and completion rates in children.
- To identify factors influencing vaccination timeliness and completion.
- To pinpoint missed opportunities for hepatitis A vaccination.
Main Methods:
- Retrospective, observational study utilizing three large healthcare claims databases.
- Analysis of children born between 2005-2009, followed for 3.5 years post-birth.
- Examination of vaccination records and healthcare utilization patterns.
Main Results:
- Initiation rates ranged from 63.8-79.4%, with completion rates from 45.1-66.8% across databases.
- A significant proportion of unvaccinated children had well visits, indicating missed opportunities.
- Factors like birth year, state mandates, HMO enrollment, and provider type influenced vaccination success.
Conclusions:
- Despite improvements, substantial gaps in hepatitis A vaccine coverage persist.
- Vaccine coverage has plateaued in recent birth cohorts.
- Proactive identification of vaccination opportunities by providers is essential to protect children.
Objectives:
To estimate hepatitis A vaccine series initiation and completion rates, assess time to vaccination, identify missed opportunities for the hepatitis A vaccine series, and examine factors associated with hepatitis A vaccine series initiation and completion.
Methods:
We conducted a retrospective, observational study using three healthcare claims databases separately. The study population was comprised of children born between years 2005 and 2009 that were continuously enrolled for at least three and a half years from the date of birth. Every child was followed from date of birth for three and a half years for hepatitis A vaccination.
Results:
There were 93,735 eligible children from Clinformatics Data Mart, 202,513 from MarketScan Commercial, and 207,545 from MarketScan Medicaid. The overall hepatitis A vaccine series initiation rate was 63.8-79.4% and completion rate was 45.1-66.8% across the three databases. About 62.8-90.1% of the children who never initiated hepatitis A vaccine had at least one well visit from 1 year to three and a half years old. Children were more likely to initiate and complete the hepatitis A vaccine series if they were from more recent birth cohorts, from states with a hepatitis A vaccination recommendation prior to the ACIP universal recommendation, from states with daycare/school entry requirements, were enrolled in an HMO health plan, had pediatricians as primary providers, had more doctor's office/well visits and received MMR/Varicella vaccines.
Conclusion:
In this study, approximately one in every three to five children remained unvaccinated against hepatitis A. Although the hepatitis A vaccine series initiation and completion improved from 2005 to 2009, vaccine coverage has stabilized in recent years. It is important for providers to identify every opportunity for hepatitis A vaccination and to assure that children get protection from this vaccine-preventable disease.
Related Concept Videos
Vaccinations
Hepatitis
Vaccines
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

